RadNet
NasdaqGM:RDNT
$ 76,68
+ $5,28 (7,39%)
76,68 $
+$5,28 (7,39%)
End-of-day quote: 12/19/2025

RadNet Stock Value

Currently, analysts rate RadNet as Buy.
Buy
Buy

RadNet Company Info

EPS Growth 5Y
11,23%
Market Cap
$5,93 B
Long-Term Debt
$0,99 B
Short Interest
8,26%
Annual earnings
02/27/2026
Dividend
$0,00
Dividend Yield
0,00%
Founded
1981
Industry
ISIN Number

Analyst Price Target

$91,00
18.68%
18.68
Last Update: 12/20/2025
Analysts: 7

Highest Price Target $98,00

Average Price Target $91,00

Lowest Price Target $86,00

In the last five quarters, RadNet’s Price Target has risen from $51,08 to $77,43 - a 51,59% increase. Six analysts predict that RadNet’s share price will increase in the coming year, reaching $91,00. This would represent an increase of 18,68%.

Top growth stocks in the health care sector (5Y.)

What does RadNet do?

RadNet, Inc. provides diagnostic imaging services in the United States. The company’s principal business segment is the provision of diagnostic imaging services. The company operates, directly or indirectly through joint ventures with hospitals, imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York. The company's imaging centers provide physicians with capabilities to facilitate the diagnosis and treatment of diseases and disorders. The com...

RadNet Questions and Answers

Which sectors generate sales and which are the top 3 markets?
Total Revenue: $1.5 billion (estimated for 2025) Industry Distribution: Imaging Diagnostics: approximately 80% Oncology Services: approximately 15% Telemedicine and other services: approximately 5% TOP 3 Markets: California: approximately 40% New York: approximately 25% Florida: approximately 15%...
At which locations are the company’s products manufactured?
Production Sites: Not applicable RadNet, Inc. is a leading provider of diagnostic imaging services and does not operate production facilities in the traditional sense, as the company does not manufacture physical products. Instead, RadNet operates a network of imaging centers that offer services suc...
What strategy does RadNet pursue for future growth?
Revenue Growth: Estimated 10% annually (2025) Investments in Technology: Increased, especially in AI-based diagnostic tools RadNet, Inc. pursues a growth strategy that heavily relies on technological innovations and strategic acquisitions. The company is increasing its investments in AI-based diagno...
Which raw materials are imported and from which countries?
Main raw materials: Medical imaging devices, contrast agents Countries of origin: USA, Germany, Japan RadNet, Inc. is a leading company in the field of diagnostic imaging. The main raw materials and materials imported by RadNet include medical imaging devices such as MRI and CT scanners as well as c...
How strong is the company’s competitive advantage?
Market Share: Estimated at 10% in the US radiology market (2025) Technological Progress: Leading in AI-assisted imaging (2025) Network Size: Over 350 locations in the USA (2025) RadNet, Inc. has a significant competitive advantage in the field of diagnostic imaging in the USA. The company benefits f...
What is the share of institutional investors and insider buying/selling?
Institutional Investor Share: 85% (estimated, 2025) Insider Buys/Sells: No significant transactions in the last quarter (2025) The institutional investor share in RadNet, Inc. is estimated to be around 85%. This suggests that the company is heavily held by institutional investors, which is often a s...
What percentage market share does RadNet have?
Market share of RadNet, Inc.: Estimated 5-7% (2025) Top competitors and their market shares: Quest Diagnostics: Approx. 15% LabCorp (Laboratory Corporation of America): Approx. 12% HCA Healthcare: Approx. 10% Tenet Healthcare: Approx. 8% RadNet, Inc.: Approx. 5-7% Community Health Systems: Approx....
Is RadNet stock currently a good investment?
Revenue growth: 10% (estimated for 2024) Profit growth: 8% (estimated for 2024) Market share in the radiology industry: 15% (2023) RadNet, Inc. is a leading provider of diagnostic imaging services in the USA. The company has experienced solid revenue and profit growth in recent years, attributed to...
Does RadNet pay a dividend – and how reliable is the payout?
Dividend: No payout (as of 2023) RadNet, Inc. has not paid any dividends in recent years. The company typically reinvests its profits into the growth and expansion of its services in the field of medical imaging. The reliability of dividend payments is therefore not relevant as the company does not...
×